These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations. Paunescu K; Wabbels B; Preising MN; Lorenz B Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):417-26. PubMed ID: 15565294 [TBL] [Abstract][Full Text] [Related]
67. A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy. Glen WB; Peterseim MMW; Badilla R; Znoyko I; Bourg A; Wilson R; Hardiman G; Wolff D; Martinez J Ophthalmic Genet; 2019 Apr; 40(2):110-117. PubMed ID: 30870047 [TBL] [Abstract][Full Text] [Related]
68. Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease. Johnson S; Buessing M; O'Connell T; Pitluck S; Ciulla TA JAMA Ophthalmol; 2019 Oct; 137(10):1115-1123. PubMed ID: 31318398 [TBL] [Abstract][Full Text] [Related]
69. Intraperitoneal chromophore injections delay early-onset and rapid retinal cone degeneration in a mouse model of Leber congenital amaurosis. Dai X; Jin X; Ye Q; Huang H; Duo L; Lu C; Bao J; Chen H Exp Eye Res; 2021 Nov; 212():108776. PubMed ID: 34582935 [TBL] [Abstract][Full Text] [Related]
70. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Cideciyan AV; Hauswirth WW; Aleman TS; Kaushal S; Schwartz SB; Boye SL; Windsor EA; Conlon TJ; Sumaroka A; Pang JJ; Roman AJ; Byrne BJ; Jacobson SG Hum Gene Ther; 2009 Sep; 20(9):999-1004. PubMed ID: 19583479 [TBL] [Abstract][Full Text] [Related]
71. Pseudo-fovea formation after gene therapy for RPE65-LCA. Cideciyan AV; Aguirre GK; Jacobson SG; Butt OH; Schwartz SB; Swider M; Roman AJ; Sadigh S; Hauswirth WW Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):526-37. PubMed ID: 25537204 [TBL] [Abstract][Full Text] [Related]
72. The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene. Hahn LC; Georgiou M; Almushattat H; van Schooneveld MJ; de Carvalho ER; Wesseling NL; Ten Brink JB; Florijn RJ; Lissenberg-Witte BI; Strubbe I; van Cauwenbergh C; de Zaeytijd J; Walraedt S; de Baere E; Mukherjee R; McKibbin M; Meester-Smoor MA; Thiadens AAHJ; Al-Khuzaei S; Akyol E; Lotery AJ; van Genderen MM; Ossewaarde-van Norel J; van den Born LI; Hoyng CB; Klaver CCW; Downes SM; Bergen AA; Leroy BP; Michaelides M; Boon CJF Ophthalmol Retina; 2022 Aug; 6(8):711-722. PubMed ID: 35314386 [TBL] [Abstract][Full Text] [Related]
73. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444 [TBL] [Abstract][Full Text] [Related]
74. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Cideciyan AV Prog Retin Eye Res; 2010 Sep; 29(5):398-427. PubMed ID: 20399883 [TBL] [Abstract][Full Text] [Related]
75. Available Evidence on Leber Congenital Amaurosis and Gene Therapy. Alkharashi M; Fulton AB Semin Ophthalmol; 2017; 32(1):14-21. PubMed ID: 27686653 [TBL] [Abstract][Full Text] [Related]
76. Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies: A Long-Term Follow-up Study. Talib M; van Schooneveld MJ; van Genderen MM; Wijnholds J; Florijn RJ; Ten Brink JB; Schalij-Delfos NE; Dagnelie G; Cremers FPM; Wolterbeek R; Fiocco M; Thiadens AA; Hoyng CB; Klaver CC; Bergen AA; Boon CJF Ophthalmology; 2017 Jun; 124(6):884-895. PubMed ID: 28341475 [TBL] [Abstract][Full Text] [Related]
78. Mutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy. Preising MN; Hausotter-Will N; Solbach MC; Friedburg C; Rüschendorf F; Lorenz B Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3463-72. PubMed ID: 22531706 [TBL] [Abstract][Full Text] [Related]
79. Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. Fischer MD; Simonelli F; Sahni J; Holz FG; Maier R; Fasser C; Suhner A; Stiehl DP; Chen B; Audo I; Leroy BP; Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254722 [TBL] [Abstract][Full Text] [Related]